Receptor-DNA binding to target auger electrons for cancer therapy. Final report, August 1, 1993--January 31, 1997
Author(s) -
Eugene R. DeSombre
Publication year - 1997
Publication title -
osti oai (u.s. department of energy office of scientific and technical information)
Language(s) - English
Resource type - Reports
DOI - 10.2172/477720
Subject(s) - dna , auger effect , auger , in vivo , radiation therapy , cancer , cancer research , estrogen receptor , cancer therapy , in vitro , receptor , biophysics , auger electron spectroscopy , chemistry , microbiology and biotechnology , medicine , biology , breast cancer , physics , biochemistry , genetics , atomic physics , nuclear physics
The goal of this program was to investigate the principle of receptor-DNA binding as a means to target Auger electron radiation for cancer therapy, and thereby to evaluate the potential of non-covalent, high-affinity, Auger electron-emitting ligands binding to a DNA associated molecule, or DNA itself, for cancer therapy. These studies were intended to assess the ability of Auger-emitting estrogens to kill estrogen receptor-positive tumor cells, determine the mean lethal dose, and determine whether they could be effective in vitro and in vivo
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom